Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Dabbs

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) casesMamatha Chivukula, Rohit Bhargava, Adam Brufsky, et al.
American Journal of Clinical Pathology|December 18, 2013
Bright-field HER2 dual in situ hybridization (DISH) assay vs fluorescence in situ hybridization (FISH): focused study of immunohistochemical 2+ casesFaye F Gao, David J Dabbs, Kristine L Cooper, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 23, 2010
Immunohistochemical profile of steroid cell tumor of the ovary: a study of 14 cases and a review of the literatureMirka W Jones, Raj Harri, David J Dabbs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 3, 2020
Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosisSwikrity Upadhyay Baskota, David J Dabbs, Beth Z Clark, et al.
American Journal of Clinical Pathology|February 8, 2017
Male Breast CancerKate M Serdy, José Pablo Leone, David J Dabbs, et al.
The Breast Journal|March 11, 2004
Sentinel lymph node micrometastasis as a predictor of axillary tumor burdenDavid J Dabbs, Mark Fung, Douglas Landsittel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 2, 2009
Characterization of high-grade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implicationsMamatha Chivukula, Akosua Domfeh, Gloria Carter, et al.
Steroids|November 27, 2012
Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systemsMatthew J Sikora, Rachel C Jankowitz, David J Dabbs, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 7, 2017
Effects of Hydrochloric Acid and Formic Acid Decalcification on Breast Tumor Biomarkers and HER2 Fluorescence In Situ HybridizationBeth Z Clark, Jennifer M Yoest, Agnieszka Onisko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 13, 2012
Impact of progesterone receptor semiquantitative immunohistochemical result on Oncotype DX recurrence score: a quality assurance study of 1074 casesBeth Z Clark, David J Dabbs, Kristine L Cooper, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) casesMamatha Chivukula, Rohit Bhargava, Adam Brufsky, et al.
American Journal of Clinical Pathology|December 18, 2013
Bright-field HER2 dual in situ hybridization (DISH) assay vs fluorescence in situ hybridization (FISH): focused study of immunohistochemical 2+ casesFaye F Gao, David J Dabbs, Kristine L Cooper, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 23, 2010
Immunohistochemical profile of steroid cell tumor of the ovary: a study of 14 cases and a review of the literatureMirka W Jones, Raj Harri, David J Dabbs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 3, 2020
Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosisSwikrity Upadhyay Baskota, David J Dabbs, Beth Z Clark, et al.
American Journal of Clinical Pathology|February 8, 2017
Male Breast CancerKate M Serdy, José Pablo Leone, David J Dabbs, et al.
The Breast Journal|March 11, 2004
Sentinel lymph node micrometastasis as a predictor of axillary tumor burdenDavid J Dabbs, Mark Fung, Douglas Landsittel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 2, 2009
Characterization of high-grade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implicationsMamatha Chivukula, Akosua Domfeh, Gloria Carter, et al.
Steroids|November 27, 2012
Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systemsMatthew J Sikora, Rachel C Jankowitz, David J Dabbs, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 7, 2017
Effects of Hydrochloric Acid and Formic Acid Decalcification on Breast Tumor Biomarkers and HER2 Fluorescence In Situ HybridizationBeth Z Clark, Jennifer M Yoest, Agnieszka Onisko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 13, 2012
Impact of progesterone receptor semiquantitative immunohistochemical result on Oncotype DX recurrence score: a quality assurance study of 1074 casesBeth Z Clark, David J Dabbs, Kristine L Cooper, et al.
Pageof 13